General Information
BounceWatch is an independent company data service, not affiliated with Curis. To contact Curis, visit curis.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Curis compare?
A PDF of Curis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Curis soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Curis on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Curis
Business keywords: Oncology, Drug Development, Immunology, Clinical Development, Hematology, Therapeutics, Cancer Treatment, Small Molecule Inhibitors, Monoclonal Antibodies, Precision Oncology, Signal Pathway Drug Technologies, Collaborative Research, Publicly-Traded Company, Biomolecular Research
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | Undisclosed | - |
|
29 Oct 2024 |
| Post IPO Equity | Undisclosed | - |
|
06 Jul 2023 |
| Post IPO Equity | Undisclosed | - |
|
03 May 2018 |
| Post IPO Equity | Undisclosed | - |
|
30 Jul 2015 |
| Post IPO Equity | Undisclosed | - |
|
24 Feb 2015 |
| Post IPO Equity | Undisclosed | - |
|
23 Dec 2011 |
| Post IPO Equity | Undisclosed | - |
|
09 Nov 2011 |
| Post IPO Equity | Undisclosed | - |
|
12 Feb 2010 |
| Post IPO Equity | Undisclosed | - |
|
08 Jan 2001 |
Curis Alternatives & Competitors
View All AlternativesTrailblazing the path to drugging transcription factors to discover precision medicines for cancer &...
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
Crafting novel therapies to enhance the length and quality of life for seriously ill patients worldw...
FAQ About Curis
Source: BounceWatch company record for Curis, https://bouncewatch.com/company/curis, updated 6 January 2025. When citing, please name BounceWatch and link this page.